We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

32 hedge funds and large institutions have $66.9M invested in Fibrocell Science Inc. in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less capital invested

Capital invested by funds: $76.6M → $66.9M (-$9.71M)

16% less funds holding

Funds holding: 3832 (-6)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
4
Reduced
7
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$40.5M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$9.23M
Jennison Associates
3
Jennison Associates
New York
$6.86M -$229K -5,674 -3%
MP
4
MSD Partners
New York
$4.47M
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.39M -$37.6K -930 -3%
CCA
6
Catalyst Capital Advisors
New York
$1.18M +$16.2K +400 +1%
HVC
7
Healthcare Value Capital
New Jersey
$409K
Geode Capital Management
8
Geode Capital Management
Massachusetts
$393K
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$352K
TMC
10
Trellus Management Company
Florida
$321K
Bank of New York Mellon
11
Bank of New York Mellon
New York
$257K
SIP
12
Stoneridge Investment Partners
Pennsylvania
$246K +$130K +3,218 +103%
Citigroup
13
Citigroup
New York
$213K -$57.1K -1,413 -20%
Goldman Sachs
14
Goldman Sachs
New York
$196K +$1.86K +46 +0.9%
Northern Trust
15
Northern Trust
Illinois
$193K
BFA
16
BlackRock Fund Advisors
California
$186K +$13.8K +342 +8%
SC
17
Saiers Capital
New York
$183K
BCM
18
Bridgeway Capital Management
Texas
$85K -$263K -6,514 -75%
Morgan Stanley
19
Morgan Stanley
New York
$70K -$54.1K -1,339 -43%
Millennium Management
20
Millennium Management
New York
$41K +$43K +1,064 New
EEG
21
E.E. Geduld
$39K
State Street
22
State Street
Massachusetts
$26K -$3.23K -80 -11%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$23K
BIM
24
BlackRock Investment Management
Delaware
$10K
BJ
25
BlackRock Japan
Japan
$8K +$8.49K +210 New

FCSC Hedge Fund Activity: Q4 2014 in Review

32 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2014, worth a combined $66.9M — down 13% from $76.6M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FCSC and 6 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Stoneridge Investment Partners, adding an estimated $130K. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $601K sold.

  • 32 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2014, down from 38 in Q3 2014.
  • Funds reported $66.9M of Fibrocell Science Inc. stock for Q4 2014, down 13% quarter-over-quarter.
  • 6 funds opened new Fibrocell Science Inc. positions in Q4 2014 and 11 closed out, a net change of -5 holders.
  • The largest Fibrocell Science Inc. buyer in Q4 2014 was Stoneridge Investment Partners, an estimated $130K added.
  • The largest Fibrocell Science Inc. seller in Q4 2014 was Cambridge Investment Research Advisors, an estimated $601K sold.

Based on aggregated 13F filings for Q4 2014.